ALX Oncology Holdings Inc. (ALXO)
NASDAQ: ALXO · Real-Time Price · USD
2.060
-0.010 (-0.48%)
At close: Jul 1, 2026, 4:00 PM EDT
2.087
+0.027 (1.33%)
After-hours: Jul 1, 2026, 4:16 PM EDT
ALX Oncology Holdings Market Cap
ALX Oncology Holdings has a market cap or net worth of $277.2 million as of July 1, 2026. Its market cap has increased by 875.68% in one year.
Market Cap
277.20M
Enterprise Value
153.29M
1-Year Change
875.68%
Ranking
Category
Stock Price
$2.06
Market Cap Chart
Since July 17, 2020, ALX Oncology Holdings's market cap has decreased from $1.06B to $277.20M, a decrease of -73.76%. That is a compound annual growth rate of -20.11%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 1, 2026 | 277.20M | 352.45% |
| Dec 31, 2025 | 61.27M | -30.44% |
| Dec 31, 2024 | 88.08M | -88.13% |
| Dec 29, 2023 | 741.80M | 61.50% |
| Dec 30, 2022 | 459.31M | -47.23% |
| Dec 31, 2021 | 870.34M | -74.66% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jul 17, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| MacroGenics | 287.31M |
| Galectin Therapeutics | 283.18M |
| Conexeu Sciences | 271.60M |
| Entrada Therapeutics | 265.21M |
| Niagen Bioscience | 261.38M |
| ProQR Therapeutics | 257.54M |
| Orchestra BioMed Holdings | 255.39M |
| Minerva Neurosciences | 255.31M |